EPR Biotech News

September 23rd 2010
Categories: Biochemicals, Biomedical Engineering, Biopharmaceutical, Biotech, Biotechnology, Pharmaceuticals, Policy, Science

No Comments

Turkey’s Biopharmaceutical Sector Attracts, Boosts Research and Development Expenditures

A recent report on the biopharmaceutical sector presence, employment, economic output and research and development activity in the European States highlights Turkey’s long-term prospects for growth. The report notes that the industry is creating a positive ripple across the region’s economy, improving the quality of life for its citizens and ...
August 29th 2008
Categories: Biochemicals, Biological Remediation, Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Consulting, DNA, FDA, Gene, Gene Therapy, Genetics, Genome, Healthcare, Law, Licenses, Medical Technologies, Medicine, Microarrays, Online, Pharmaceuticals, Policy, Proteomics, Regulations, Science, Tissue Engineering, Vaccines

One Comment

Welcome to EPR Biotech News

EPR Biotech News is a new blog, part of EPR Network, that is going to be focused on and will be covering the biotech news and stories from press releases published on EPR Network. EPR Network (EPR stands for express press release) is one of the nation’s largest press release distribution networks on Web. The EPR’s nationwide network includes 12 State based ...

Pages

 

February 2012
M T W T F S S
« Jan    
 12345
6789101112
13141516171819
20212223242526
272829  

Advertisements

Categories

Recent Posts

Tags

Blogroll

Archives

Meta

January 25th 2012
Tags: Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Genetics, Pharmaceuticals No Comments

Advinus, SignalChem Start The Multi-Year, Multi-Target Collaboration On New Anti-Cancer Drugs

Advinus Therapeutics, a research-based pharmaceutical development company promoted by the TATA Group, and SignalChem Pharmaceuticals, a British Columbia-based drug discovery company, have started working on 15 programs based on SignalChem’s proprietary Kinase platform for targeted therapies in oncology. Each program is being developed with corresponding diagnostics and tracers for patient ...
November 24th 2011
Tags: Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Genetics, Pharmaceuticals No Comments

CYTOO Raises 10 M$ (7M€) in Series C Round

CYTOO SA, a company that specializes in cell-based assays, is pleased to announce the closing of a series C funding round of USD 10M (EUR 7M). New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors AURIGA Partners and Jacques Lewiner, co-founder and president of the supervisory board ...

Search

The archives run deep. Feel free to search older content using topic keywords.